HDFC Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1967 Cr | ₹8346 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.14 | 1.82 |
| Manager | Dhruv Muchhal | Sailesh Raj Bhan |
| ISIN Code | INF179KC1HL7 | INF204K01968 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -0.6% | -0.47% |
| 6 Month | 3.81% | -0.39% |
| 1 Year | 5.22% | 0.28% |
| 3 Year | - | 21.45% |
| 5 Year | - | 15.91% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -0.32% | -0.82% |
| 1 Year | 9.85% | 4.97% |
| 3 Year | - | 16.4% |
| 5 Year | - | 16.13% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 27.59% | 16.7% |
| 3 Year | - | 20.91% |
| 5 Year | - | 20.41% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 14.36% |
| Sharp | - | 0.98% |
| Beta | - | 0.87% |
| Alpha | - | 1.45% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Dhruv Muchhal | Sailesh Raj Bhan |
| Total AUM | ₹520687 Cr | ₹96086 Cr |
| Funds Managed | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 10.09 | 1.24 |
| Mid Cap | 30.15 | 35.11 |
| Small Cap | 33.66 | 31 |
| Large Cap | 26.1 | 32.65 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.71 | 0.34 |
| Basic Materials | 2.86 | - |
| Healthcare | 95.43 | 99.66 |
Top Comparisons
Aditya Birla Sun Life Balanced Advantage Fund - Regular Plan - Growth Option
3Y Returns12.62%
Kotak Balanced Advantage Fund -Regular Plan - Growth Option
3Y Returns11.56%
Sundaram Aggressive Hybrid Fund (Formerly Known as Principal Hybrid Equity Fund)-Growth
3Y Returns12.11%
INVESCO INDIA AGGRESSIVE HYBRID FUND - Regular Plan - Growth
3Y Returns15.15%
Mirae Asset Multi Asset Allocation Fund-Reg (G)
3Y Returns0%
UTI Multi Asset Allocation Fund - Regular Plan - Growth Option
3Y Returns19.37%
ITI Overnight Fund Regular - Growth
3Y Returns6.1%
Aditya Birla Sun Life Overnight Fund-Regular Plan-Growth
3Y Returns6.31%